NO20022446D0 - Etere av O-desmetyl-venlafaxine - Google Patents

Etere av O-desmetyl-venlafaxine

Info

Publication number
NO20022446D0
NO20022446D0 NO20022446A NO20022446A NO20022446D0 NO 20022446 D0 NO20022446 D0 NO 20022446D0 NO 20022446 A NO20022446 A NO 20022446A NO 20022446 A NO20022446 A NO 20022446A NO 20022446 D0 NO20022446 D0 NO 20022446D0
Authority
NO
Norway
Prior art keywords
desmethyl
venlafaxine
ethers
Prior art date
Application number
NO20022446A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022446L (no
Inventor
John Patrick Yardley
Magid Abdel-Megid Abou-Gharbia
John William Ullrich
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20022446D0 publication Critical patent/NO20022446D0/no
Publication of NO20022446L publication Critical patent/NO20022446L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NO20022446A 1999-11-24 2002-05-23 Etere av O-desmetyl-venlafaxine NO20022446L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44826899A 1999-11-24 1999-11-24
PCT/US2000/031895 WO2001038293A1 (en) 1999-11-24 2000-11-21 Ethers of o-desmethyl venlafaxine

Publications (2)

Publication Number Publication Date
NO20022446D0 true NO20022446D0 (no) 2002-05-23
NO20022446L NO20022446L (no) 2002-05-23

Family

ID=23779642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022446A NO20022446L (no) 1999-11-24 2002-05-23 Etere av O-desmetyl-venlafaxine

Country Status (24)

Country Link
EP (1) EP1232141B1 (de)
JP (1) JP2003514889A (de)
KR (1) KR100843991B1 (de)
CN (2) CN1636559A (de)
AR (1) AR024498A1 (de)
AT (1) ATE278659T1 (de)
AU (1) AU767835B2 (de)
BR (1) BR0015795A (de)
CA (1) CA2391288A1 (de)
CZ (1) CZ20021816A3 (de)
DE (1) DE60014693T2 (de)
DK (1) DK1232141T3 (de)
ES (1) ES2228636T3 (de)
HU (1) HUP0203594A2 (de)
IL (2) IL149531A0 (de)
MX (1) MXPA02005174A (de)
NO (1) NO20022446L (de)
NZ (1) NZ519130A (de)
PL (1) PL202846B1 (de)
PT (1) PT1232141E (de)
SI (1) SI1232141T1 (de)
TW (1) TWI268919B (de)
WO (1) WO2001038293A1 (de)
ZA (1) ZA200204986B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
SG188637A1 (en) * 2010-10-01 2013-05-31 Shan Dong Luye Pharm Co Ltd Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
CN103319373B (zh) * 2012-03-23 2017-09-19 浙江九洲药业股份有限公司 1‑[2‑氨基‑1‑(4‑苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体

Also Published As

Publication number Publication date
IL149531A (en) 2008-12-29
DE60014693D1 (en) 2004-11-11
PL355171A1 (en) 2004-04-05
ZA200204986B (en) 2003-09-27
CZ20021816A3 (cs) 2002-08-14
CN1636559A (zh) 2005-07-13
AR024498A1 (es) 2002-10-02
KR20030058931A (ko) 2003-07-07
DK1232141T3 (da) 2004-11-29
SI1232141T1 (en) 2004-12-31
BR0015795A (pt) 2002-07-23
AU1783301A (en) 2001-06-04
MXPA02005174A (es) 2002-11-07
CA2391288A1 (en) 2001-05-31
ATE278659T1 (de) 2004-10-15
WO2001038293A1 (en) 2001-05-31
HUP0203594A2 (en) 2003-02-28
NZ519130A (en) 2003-09-26
NO20022446L (no) 2002-05-23
PT1232141E (pt) 2004-12-31
ES2228636T3 (es) 2005-04-16
PL202846B1 (pl) 2009-07-31
IL149531A0 (en) 2002-11-10
CN1399626A (zh) 2003-02-26
JP2003514889A (ja) 2003-04-22
EP1232141A1 (de) 2002-08-21
DE60014693T2 (de) 2005-03-10
EP1232141B1 (de) 2004-10-06
HK1045835A1 (en) 2002-12-13
CN1198793C (zh) 2005-04-27
TWI268919B (en) 2006-12-21
AU767835B2 (en) 2003-11-27
KR100843991B1 (ko) 2008-07-07

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
ID30233A (id) Antibiotika ketolida
IS2325B (is) Örgerðar samsetningar epleróns
AR028596A1 (es) Nuevos derivados de fenilglicina
DE60008422D1 (de) Pour-on formulierungen
EE200200150A (et) Preparaat
NO990431D0 (no) Golfk°llehode
ATE270270T1 (de) Neuartige phenylalkyloxy-phenyl-derivate
IS6398A (is) Lyfjablöndur
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
PT1022396E (pt) Combinacao de duche
DE50015795D1 (de) Sektionaltor
FI990937A0 (fi) Tilaajahallinta
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
ID30023A (id) Kombinasi senyawa aktif fungisida
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200200389A (et) Imidasooli uued derivaadid
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20022446D0 (no) Etere av O-desmetyl-venlafaxine
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
NO20021234D0 (no) Anvendelse av tienopyrimidiner
SE9902239D0 (sv) Kornisch bestående av flera delar
EE200200053A (et) Isoretinoiini valmistamise protsess

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application